Final Deadline Approaching on June 27, 2022: Kessler Topaz Meltzer & Check, LLP Reminds Natera, Inc. Investors of Class Action Lawsuit DeadlineNewsfile Corp • 06/19/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Natera, Inc. (NTRA) Investors with Losses to Contact Firm's Attorneys, June 27th Deadline Approaching in Securities Class ActionNewsfile Corp • 06/18/22
Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Natera, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors to Contact the FirmNewsfile Corp • 06/17/22
Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Natera, Inc.PRNewsWire • 06/16/22
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Natera, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 27, 2022 - (NTRA)Newsfile Corp • 06/16/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Natera, Inc. Investors to Secure Counsel Before Important June 27 Deadline in Securities Class Action - NTRAPRNewsWire • 06/15/22
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 06/15/22
NTRA FINAL DEADLINE NOTICE: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Natera, Inc. Investors with Losses to Secure Counsel Before Important June 27 Deadline in Securities Class Action - NTRANewsfile Corp • 06/14/22
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Natera, Inc. Investors of Upcoming Lead Plaintiff DeadlineBusiness Wire • 06/14/22
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 06/13/22
Kessler Topaz, Meltzer & Check, LLP Encourages Natera, Inc. Investors with Substantial Losses to Contact the FirmNewsfile Corp • 06/11/22
ROSEN, A Leading Law Firm, Encourages Natera, Inc. Investors with Losses to Secure Counsel Before Important June 27 Deadline in Securities Class Action - NTRANewsfile Corp • 06/11/22
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 06/10/22
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 06/09/22
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit against Natera, Inc. and Encourages Investors with Substantial Losses to Contact the FirmNewsfile Corp • 06/08/22
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Natera, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 06/08/22
Natera Showcases Leadership in Transplantation at ATC 2022 with New Data on its Prospera and Renasight TestsPRNewsWire • 06/08/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Natera, Inc. Investors With Losses Over $100K to Secure Counsel Before Important June 27 Deadline in Securities Class Action - NTRAPRNewsWire • 06/07/22
CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Investors that a Securities Fraud Class Action Lawsuit Has Been Filed Against Natera, Inc.Newsfile Corp • 06/06/22
NATERA SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Natera, Inc. - NTRAPRNewsWire • 06/04/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Natera, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - NTRANewsfile Corp • 06/02/22
Important June 27, 2022 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Natera, Inc. Investors of Securities Fraud Class Action LawsuitNewsfile Corp • 06/01/22
NATERA, INC. (NASDAQ: NTRA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Natera, Inc. (NASDAQ: NTRA)PRNewsWire • 06/01/22
Natera to Present New Signatera™ Clinical Data Across Multiple Cancer Types at the 2022 ASCO Annual MeetingPRNewsWire • 05/31/22